for Opioid Use Disorder
LifeKit® Predict is a genetic risk assessment for opioid use disorder (OUD). Using a simple cheek swab test, LifeKit Predict provides patients and healthcare providers with objective, personalized risk information for OUD to support informed decision-making about the use of oral opioids for acute pain relief.
A New Risk Assessment
Tool for OUD
Objective Risk Prediction
LifeKit Predict analyzes 15 genetic variants involved in the brain reward pathway to identify patients who may be at increased genetic risk for opioid use disorder.
LifeKit Predict helps providers make informed decisions about the use of oral opioids for acute pain relief when developing a pain management plan.
Seamless Workflow Integration
LifeKit Predict is compatible with existing guidelines that recommend providers conduct a risk assessment for opioid use disorder.1
How It Works
Empowered Pain Management
LifeKit Predict, intended to be used in combination with a clinical evaluation and assessment of the patient, can help you assess OUD risk when developing a pain management plan for your patients.
Learn More About Opioid Prescribing
Interested in learning more? Send us a message.
*Why are we collecting this data?